Is a complete VMD research report available?

No complete published report is available for Viemed Healthcare, Inc. (VMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Viemed Healthcare, Inc. (VMD)

NASDAQ: VMD · USD

$9.98

+0.30 (+3.1%)· Recorded snapshot

Market cap	380.1M
Revenue (ttm)	301.6M
Net income (ttm)	14.5M
EPS (ttm)	$0.36
Shares out	38.1M
P/E (trailing)	27.7x
P/E (forward)	20.1x
Volume	170,904
Beta	1.04

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001729149
Company name	Viemed Healthcare, Inc.
Country	United States
Country code	US
CUSIP number	92663R105
Earnings date	2026-11-04
Earnings time	amc
Employees	1,438
Employees change	180
Employees growth	14.31%
Enterprise value	$381M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2006
In index	RUSSELL2000
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	CA92663R1055
Last 10-K release date	2026-03-04
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$380.1M
Market cap category	Small-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$9.98
Price currency	USD
Sector	Healthcare
SIC code	8090
Stock price date	2026-10-28
Symbol	VMD
U.S. state	Louisiana
Website	https://www.viemed.com

Metric

Value

Amount currency

USD

CIK code

0001729149

Company name

Viemed Healthcare, Inc.

Country

United States

Country code

CUSIP number

92663R105

Earnings date

2026-11-04

Earnings time

amc

Employees

1,438

Employees change

180

Employees growth

14.31%

Enterprise value

$381M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2006

In index

RUSSELL2000

Industry

Medical Devices

Is primary listing

Yes

Is SPAC

ISIN number

CA92663R1055

Last 10-K release date

2026-03-04

Last earnings date

2026-08-03

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$380.1M

Market cap category

Small-Cap

Next earnings date

2026-11-04

Options

Yes

Price

$9.98

Price currency

USD

Sector

Healthcare

SIC code

8090

Stock price date

2026-10-28

Symbol

VMD

U.S. state

Louisiana

Website

https://www.viemed.com

Metric	Value
Average P/E ratio (10Y)	25.27x
Average P/E ratio (3Y)	25.83x
Average P/E ratio (5Y)	29.41x
Earnings yield	3.61%
EV/Earnings	25.78x
EV/EBIT	14.63x
EV/EBITDA	6.7x
EV/FCF	12.79x
EV/Sales	1.24x
FCF / EV yield	7.82%
FCF yield	7.84%
Forward EV/Sales	1.12x
Forward P/E	20.09x
Forward P/S	1.12x
Graham number	5.53845
Graham upside	-43.43%
Industry forward P/E	19.81x
Industry P/E	39.28x
Lynch fair value	$1.96
Lynch upside	-79.97%
P/(FCF - SBC) ratio	18.39x
P/(OCF - SBC) ratio	7.2x
P/B ratio	2.56x
P/E ratio	27.68x
P/FCF ratio	12.75x
P/OCF ratio	6.13x
P/S ratio	1.24x
Price / tangible book value	4.44x
Price/EBITDA ratio	6.68x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Average P/E ratio (10Y)

25.27x

Average P/E ratio (3Y)

25.83x

Average P/E ratio (5Y)

29.41x

Earnings yield

3.61%

EV/Earnings

25.78x

EV/EBIT

14.63x

EV/EBITDA

6.7x

EV/FCF

12.79x

EV/Sales

1.24x

FCF / EV yield

7.82%

FCF yield

7.84%

Forward EV/Sales

1.12x

Forward P/E

20.09x

Forward P/S

1.12x

Graham number

5.53845

Graham upside

-43.43%

Industry forward P/E

19.81x

Industry P/E

39.28x

Lynch fair value

$1.96

Lynch upside

-79.97%

P/(FCF - SBC) ratio

18.39x

P/(OCF - SBC) ratio

7.2x

P/B ratio

2.56x

P/E ratio

27.68x

P/FCF ratio

12.75x

P/OCF ratio

6.13x

P/S ratio

1.24x

Price / tangible book value

4.44x

Price/EBITDA ratio

6.68x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
EBIT margin	8.47%
EBITDA margin	18.5%
Effective tax rate	29.05%
FCF margin	9.69%
Gross margin	57.47%
Operating margin	8.47%
Pretax margin	7.02%
Profit margin	4.81%
Profit per employee	$10,082
Profitable quarters	33
Profitable years	9
Revenue per employee	$209,740
ROA	8.21%
ROA (5Y)	6.16%
ROCE	16.34%
ROE	10.45%
ROE (5Y)	9.37%
ROIC	12.27%
ROIC (5Y)	10.37%
SBC / revenue	2.97%
Tax / revenue	2.04%

Metric

Value

EBIT margin

8.47%

EBITDA margin

18.5%

Effective tax rate

29.05%

FCF margin

9.69%

Gross margin

57.47%

Operating margin

8.47%

Pretax margin

7.02%

Profit margin

4.81%

Profit per employee

$10,082

Profitable quarters

Profitable years

Revenue per employee

$209,740

ROA

8.21%

ROA (5Y)

6.16%

ROCE

16.34%

ROE

10.45%

ROE (5Y)

9.37%

ROIC

12.27%

ROIC (5Y)

10.37%

SBC / revenue

2.97%

Tax / revenue

2.04%

Metric	Value
EPS growth	6.51%
EPS growth (Q)	-12.38%
EPS growth (QoQ)	16.67%
EPS growth 3Y	23.75%
EPS growth 5Y	5.62%
EPS growth years	3
FCF growth (Q)	80.41%
FCF growth (QoQ)	447.61%
FCF growth 3Y	38.07%
FCF growth 5Y	25.02%
Gross profit growth	23.34%
Gross profit growth (Q)	22.64%
Gross profit growth 3Y	22.34%
Gross profit growth 5Y	18.56%
Net income growth	3.74%
Net income growth (Q)	-12.45%
Net income growth (QoQ)	7.05%
Net income growth 3Y	25.47%
Net income growth 5Y	5.44%
Net income growth years	3
OCF growth	41.88%
OCF growth (Q)	29.77%
OCF growth (QoQ)	97.03%
OCF growth 3Y	21.63%
OCF growth 5Y	22.61%
Operating income growth	53.91%
Operating income growth (Q)	12.12%
Operating income growth 3Y	34.49%
Operating income growth 5Y	13.17%
Revenue growth	25.21%
Revenue growth (Q)	23.85%
Revenue growth (QoQ)	3.56%
Revenue growth 3Y	24.54%
Revenue growth 5Y	20.15%
Revenue growth quarters	19
Revenue growth years	4

Metric

Value

EPS growth

6.51%

EPS growth (Q)

-12.38%

EPS growth (QoQ)

16.67%

EPS growth 3Y

23.75%

EPS growth 5Y

5.62%

EPS growth years

FCF growth (Q)

80.41%

FCF growth (QoQ)

447.61%

FCF growth 3Y

38.07%

FCF growth 5Y

25.02%

Gross profit growth

23.34%

Gross profit growth (Q)

22.64%

Gross profit growth 3Y

22.34%

Gross profit growth 5Y

18.56%

Net income growth

3.74%

Net income growth (Q)

-12.45%

Net income growth (QoQ)

7.05%

Net income growth 3Y

25.47%

Net income growth 5Y

5.44%

Net income growth years

OCF growth

41.88%

OCF growth (Q)

29.77%

OCF growth (QoQ)

97.03%

OCF growth 3Y

21.63%

OCF growth 5Y

22.61%

Operating income growth

53.91%

Operating income growth (Q)

12.12%

Operating income growth 3Y

34.49%

Operating income growth 5Y

13.17%

Revenue growth

25.21%

Revenue growth (Q)

23.85%

Revenue growth (QoQ)

3.56%

Revenue growth 3Y

24.54%

Revenue growth 5Y

20.15%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-31.5M
Depreciation and amortization	$30.3M
EBIT	$25.5M
EBITDA	$55.8M
EPS	$0.36
FCF per share	$0.77
Financing cash flow	$-16.9M
Free cash flow	$29.2M
Free cash flow minus SBC	$20.3M
Gross profit	$173.3M
Income taxes	$6.2M
Investing cash flow	$-53.2M
Net borrowing	$3.1M
Net cash flow	$-9.3M
Net income	$14.5M
Operating cash flow minus SBC	$51.8M
Operating income	$25.5M
Revenue	$301.6M
Stock-based compensation	$9M

Metric

Value

Capital expenditures

$-31.5M

Depreciation and amortization

$30.3M

EBIT

$25.5M

EBITDA

$55.8M

EPS

$0.36

FCF per share

$0.77

Financing cash flow

$-16.9M

Free cash flow

$29.2M

Free cash flow minus SBC

$20.3M

Gross profit

$173.3M

Income taxes

$6.2M

Investing cash flow

$-53.2M

Net borrowing

$3.1M

Net cash flow

$-9.3M

Net income

$14.5M

Operating cash flow minus SBC

$51.8M

Operating income

$25.5M

Revenue

$301.6M

Stock-based compensation

$9M

Metric	Value
Altman Z-Score	5.82
Book value per share	$3.78
Debt / EBITDA	0.2
Debt / equity	0.08
Debt / FCF	0.4
Goodwill	$58.9M
Interest coverage	17.94
Long-term assets	$150.3M
Long-term liabilities	$10.4M
Net cash (debt)	$-920,000
Net cash / market cap	-0.25%
Net debt / EBITDA	0.02
Net debt / equity	0.01
Net debt / FCF	0.03
Piotroski F-Score	5
Property, plant and equipment	$81.7M
Shareholders' equity	$146M
Tangible book value	$83.9M
Tangible book value per share	$2.20
Total assets	$204.2M
Total cash	$10.7M
Total debt	$11.6M
Total liabilities	$58.3M
WACC	9.94%

Metric

Value

Altman Z-Score

5.82

Book value per share

$3.78

Debt / EBITDA

0.2

Debt / equity

0.08

Debt / FCF

0.4

Goodwill

$58.9M

Interest coverage

17.94

Long-term assets

$150.3M

Long-term liabilities

$10.4M

Net cash (debt)

$-920,000

Net cash / market cap

-0.25%

Net debt / EBITDA

0.02

Net debt / equity

0.01

Net debt / FCF

0.03

Piotroski F-Score

Property, plant and equipment

$81.7M

Shareholders' equity

$146M

Tangible book value

$83.9M

Tangible book value per share

$2.20

Total assets

$204.2M

Total cash

$10.7M

Total debt

$11.6M

Total liabilities

$58.3M

WACC

9.94%

Metric	Value
Asset turnover	1.55
Current assets	$54M
Current liabilities	$47.9M
Current ratio	1.13
Inventory turnover	26.75
Net working capital	$-2.5M
Quick ratio	0.9
Working capital	$6.1M
Working capital turnover	25.04

Metric

Value

Asset turnover

1.55

Current assets

$54M

Current liabilities

$47.9M

Current ratio

1.13

Inventory turnover

26.75

Net working capital

$-2.5M

Quick ratio

0.9

Working capital

$6.1M

Working capital turnover

25.04

Metric	Value
Buyback yield / dilution	1.92%
Dividend yield	0%
Shareholder yield	1.92%

Metric

Value

Buyback yield / dilution

1.92%

Dividend yield

Shareholder yield

1.92%

Metric	Value
150-day SMA	$9.92
1D price change	3.1%
1M price change	12.01%
1M total return	12.01%
1W price change	2.36%
1W total return	2.36%
1Y price change	43.6%
1Y return CAGR	43.63%
1Y total return	43.6%
20-day SMA	$9.57
200-day SMA	$9.54
3M price change	-17.66%
3M total return	-17.66%
3Y price change	65.23%
3Y return CAGR	18.22%
3Y total return	65.23%
50-day SMA	$9.18
50-day SMA vs 200-day SMA	50under200
52-week high	$12.61
52-week high date	2026-07-13
52-week low	$6.05
52-week low date	2025-11-06
5Y price change	78.21%
5Y return CAGR	12.25%
5Y total return	78.21%
6M price change	1.01%
6M total return	1.01%
All-time high	$12.61
All-time high date	2026-07-13
All-time low	$1.68
All-time low date	2018-01-04
Average true range (ATR)	$0.25
Average volume	212.8K
Beta (1Y)	-0.45
Beta (2Y)	0.5
Beta (5Y)	1.04
Change from 52-week high	-20.86%
Change from 52-week low	64.96%
Change from all-time high	-20.86%
Change from all-time low	492.99%
Change from open	2.15%
Day's gap	0.93%
Dollar volume	$1.7M
High price	$10.00
Low price	$9.77
Monthly RSI	57.17
Open price	$9.77
Position in 52-week range	91.3%
Premarket change	3.2%
Premarket close	$9.68
Premarket price	$9.99
Premarket volume	605
Previous close	$9.68
Price vs 150-day SMA	0.57%
Price vs 20-day SMA	4.25%
Price vs 200-day SMA	4.59%
Price vs 50-day SMA	8.68%
Relative volume	0.81
RSI	64.71
Sharpe ratio	1.03
Sharpe ratio (3Y)	0.49
Sharpe ratio (5Y)	0.38
Sortino ratio	1.51
Sortino ratio (3Y)	0.85
Sortino ratio (5Y)	0.68
Volume	170.9K
Weekly RSI	55.81
YTD price change	34.32%
YTD total return	34.32%

Metric

Value

150-day SMA

$9.92

1D price change

3.1%

1M price change

12.01%

1M total return

12.01%

1W price change

2.36%

1W total return

2.36%

1Y price change

43.6%

1Y return CAGR

43.63%

1Y total return

43.6%

20-day SMA

$9.57

200-day SMA

$9.54

3M price change

-17.66%

3M total return

-17.66%

3Y price change

65.23%

3Y return CAGR

18.22%

3Y total return

65.23%

50-day SMA

$9.18

50-day SMA vs 200-day SMA

50under200

52-week high

$12.61

52-week high date

2026-07-13

52-week low

$6.05

52-week low date

2025-11-06

5Y price change

78.21%

5Y return CAGR

12.25%

5Y total return

78.21%

6M price change

1.01%

6M total return

1.01%

All-time high

$12.61

All-time high date

2026-07-13

All-time low

$1.68

All-time low date

2018-01-04

Average true range (ATR)

$0.25

Average volume

212.8K

Beta (1Y)

-0.45

Beta (2Y)

0.5

Beta (5Y)

1.04

Change from 52-week high

-20.86%

Change from 52-week low

64.96%

Change from all-time high

-20.86%

Change from all-time low

492.99%

Change from open

2.15%

Day's gap

0.93%

Dollar volume

$1.7M

High price

$10.00

Low price

$9.77

Monthly RSI

57.17

Open price

$9.77

Position in 52-week range

91.3%

Premarket change

3.2%

Premarket close

$9.68

Premarket price

$9.99

Premarket volume

605

Previous close

$9.68

Price vs 150-day SMA

0.57%

Price vs 20-day SMA

4.25%

Price vs 200-day SMA

4.59%

Price vs 50-day SMA

8.68%

Relative volume

0.81

RSI

64.71

Sharpe ratio

1.03

Sharpe ratio (3Y)

0.49

Sharpe ratio (5Y)

0.38

Sortino ratio

1.51

Sortino ratio (3Y)

0.85

Sortino ratio (5Y)

0.68

Volume

170.9K

Weekly RSI

55.81

YTD price change

34.32%

YTD total return

34.32%

Metric	Value
Float	30.6M
Float percentage	80.45%
Shares change (QoQ)	1.57%
Shares change (YoY)	-1.92%
Shares held by insiders	13.93%
Shares held by institutions	62.36%
Shares outstanding	38.1M
Short % of float	5.12%
Short % of shares	4.12%
Short ratio	5.8 days

Metric

Value

Float

30.6M

Float percentage

80.45%

Shares change (QoQ)

1.57%

Shares change (YoY)

-1.92%

Shares held by insiders

13.93%

Shares held by institutions

62.36%

Shares outstanding

38.1M

Short % of float

5.12%

Short % of shares

4.12%

Short ratio

5.8 days

Viemed Healthcare, Inc. (VMD)

Price

Financial snapshot

Fair-value bridge

Latest news · VMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VMD

Frequently asked questions